ArticleClinical epigenetics2025

Genome-wide methylation analysis of circulating cell-free DNA identifies an episignature in lung cancer: validation of EMP2 as a potential biomarker.

Ester Alemany-Cosme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.